Galderma Group AG

BATS-CHIXE:GALDZ Stock Report

Market Cap: CHF 26.3b

Galderma Group Management

Management criteria checks 2/4

Galderma Group's CEO is Flemming Ornskov, appointed in Jan 2022, has a tenure of 3.08 years. directly owns 0.69% of the company’s shares, worth CHF181.52M. The average tenure of the management team and the board of directors is 2.9 years and 3.1 years respectively.

Key information

Flemming Ornskov

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure3.1yrs
CEO ownership0.7%
Management average tenure2.9yrs
Board average tenure3.1yrs

Recent management updates

No updates

Recent updates


CEO

Flemming Ornskov (66 yo)

3.1yrs

Tenure

Dr. Flemming Ornskov, M.D., MBA, MPH, serves as Chief Executive Officer at Galderma S.A. He is a Director and Chief Executive Officer of Galderma Group AG since 2022. He served as Member of the Supervisory...


Leadership Team

NamePositionTenureCompensationOwnership
Flemming Ornskov
CEO & Director3.1yrsno data0.69%
CHF 181.5m
Thomas J. Dittrich
Chief Financial Officer5.3yrsno data0.25%
CHF 65.8m
Adrian Murphy
Head of Global Operations2.8yrsno data0.0076%
CHF 2.0m
Emil Ivanov
Head of Strategyno datano datano data
Christian Marcoux
Chief Communications Officerno datano datano data
Allison Pinkham
Chief Human Resources Officer2.7yrsno data0.022%
CHF 5.8m

2.9yrs

Average Tenure

57yo

Average Age

Experienced Management: GALDZ's management team is considered experienced (2.9 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Flemming Ornskov
CEO & Director3.1yrsno data0.69%
CHF 181.5m
Thomas Ebeling
Independent Chairman3.1yrsno data0.23%
CHF 61.1m
Michael Bauer
Director3.1yrsno datano data
L. Browne
Independent Director3.1yrsno data0.0075%
CHF 2.0m
Marcus Brennecke
Director1.1yrsno datano data
Sherilyn S. McCoy
Independent Vice Chairman3.1yrsno data0.011%
CHF 2.9m
Maria Hilado
Independent Director3.1yrsno data0.0047%
CHF 1.2m
Karen Ling
Director3.1yrsno data0.0047%
CHF 1.2m

3.1yrs

Average Tenure

63yo

Average Age

Experienced Board: GALDZ's board of directors are considered experienced (3.1 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/02 14:39
End of Day Share Price 2025/01/31 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Galderma Group AG is covered by 14 analysts. 10 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Bethan DaviesBerenberg
Richard ParkesBNP Paribas Exane
Joffrey MellerBofA Global Research